Current Management Strategies for Cutaneous T-Cell Lymphoma

    May 2004 in “ Clinics in Dermatology ”
    Elizabeth Knobler
    Image of study
    TLDR The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.
    In May 2004, a document outlined the treatment strategies for cutaneous T-cell lymphoma (CTCL), a skin-involved lymphoma with generally good prognosis. Early-stage CTCL treatments included topical agents like corticosteroids, nitrogen mustard, and bexarotene gel, as well as phototherapy with UVB light, PUVA, or photodynamic therapy. Advanced CTCL required more aggressive treatments such as total skin electron beam radiation, interferon alpha, denileukin diftitox, extracorporeal photochemotherapy, and potentially allogeneic hematopoietic stem cell transplantation. The document highlighted the importance of tailoring treatment to the disease stage and individual patient, with a focus on balancing treatment toxicity against benefits. It also noted that while there is no cure for CTCL, many patients have a long life expectancy. Specific treatments like bexarotene showed a 54% response rate for refractory stage IA-IIA disease, and interferon alpha achieved a 41% complete remission in a long-term study. Side effects were discussed for each treatment, and the need for individualized treatment plans was emphasized due to the potential for relapse and the varying response rates. Combination therapies and the potential of allogeneic HSCT for refractory cases were also mentioned, although further studies were needed to confirm their effectiveness.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 18 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  41 upvotes 6 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Being Safe on Oral Minoxidil: tl;dr on the literature.

      in Research/Science  51 upvotes 1 year ago
      Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

      community How do you use rosemary oil and peppermint oil?

      in Question  6 upvotes 6 years ago
      Rosemary oil and peppermint oil may promote hair growth and increase cutaneous blood flow, showing promise as treatments for androgenetic alopecia. Minoxidil 2% is also used for treating hair loss.

      community Scientific evidence for Peppermint & Rosemary oils + My Experience

      in Research/Science  114 upvotes 3 years ago
      Natural treatments for hair loss, specifically peppermint oil and rosemary oil; how they can be used as a supplementary or alternative treatment to pharmaceuticals such as finasteride and minoxidil; and the personal experience of the user Divallo, who has seen an increase in density and thickness after using these oils for around 2.5 years. The post also touches on the potential antifungal properties of the oils and their effects on cutaneous blood flow.

      community Not sure if fin is enough, still losing lots of hair

      in Finasteride/Dutasteride  6 upvotes 1 year ago
      The user has been on finasteride for 17 months to treat hair loss, with some improvement in the crown but still experiencing significant shedding. They are considering if finasteride alone is sufficient and are hesitant to use minoxidil due to a pre-existing condition, while another person suggests trying dutasteride.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  63 upvotes 2 years ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Related Research

    1 / 1 results